Ivan Foeldvari

13.3k total citations · 1 hit paper
178 papers, 3.6k citations indexed

About

Ivan Foeldvari is a scholar working on Hematology, Pathology and Forensic Medicine and Speech and Hearing. According to data from OpenAlex, Ivan Foeldvari has authored 178 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Hematology, 61 papers in Pathology and Forensic Medicine and 56 papers in Speech and Hearing. Recurrent topics in Ivan Foeldvari's work include Autoimmune and Inflammatory Disorders Research (108 papers), Adolescent and Pediatric Healthcare (56 papers) and Systemic Sclerosis and Related Diseases (52 papers). Ivan Foeldvari is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (108 papers), Adolescent and Pediatric Healthcare (56 papers) and Systemic Sclerosis and Related Diseases (52 papers). Ivan Foeldvari collaborates with scholars based in Germany, United States and Italy. Ivan Foeldvari's co-authors include Gerd Horneff, Angela Wierk, Kirsten Minden, Gerd Ganser, Ulf Müller‐Ladner, L. Czirják, Christopher P. Denton, Daniel E. Furst, Oliver Distler and Ariane Klein and has published in prestigious journals such as Annals of the Rheumatic Diseases, The Journal of Pediatrics and British Journal of Ophthalmology.

In The Last Decade

Ivan Foeldvari

158 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis

2017 320 citations Ivan Foeldvari, Marco Matucci‐Cerinic et al. Journal of Scleroderma and Related Disorders profile →

Peers

Countries citing papers authored by Ivan Foeldvari

Since Specialization

Citations

This map shows the geographic impact of Ivan Foeldvari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Foeldvari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Foeldvari more than expected).

Fields of papers citing papers by Ivan Foeldvari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan Foeldvari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Foeldvari. The network helps show where Ivan Foeldvari may publish in the future.

Co-authorship network of co-authors of Ivan Foeldvari

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan Foeldvari. A scholar is included among the top collaborators of Ivan Foeldvari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan Foeldvari. Ivan Foeldvari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Monitoring of Juvenile Idiopathic Arthritis–Associated Uveitis in Long‐Term Disease Remission: Consensus‐Based Recommendations From the Multinational Interdisciplinary Working Group for Uveitis in Childhood 2025 ·Arthritis Care & Research ·Ivan Foeldvari, Ameenat Lola Solebo, Harry Petrushkin, Sheila T. Angeles‐Han, Regitze Bangsgaard, (unknown), Tamás Constantin, Joke de Boer, (unknown), Mia Glerup, (unknown), Sebastian Krämer, Elisabetta Miserocchi, Ellen Nordal, Rotraud K. Saurenmann, (unknown), Joost F. Swart, (unknown), Jordi Antón	0
2	Sarilumab in Polyarticular‐Course Juvenile Idiopathic Arthritis: Dose‐Finding and 1‐Year Analysis of a Phase 2b, Open‐Label, Multicenter Study 2025 ·Arthritis Care & Research ·Fabrizio De Benedetti, (unknown), (unknown), Ivan Foeldvari, (unknown), (unknown), Nadina Rubio‐Pérez, Pierre Quartier, Zbigniew Żuber, (unknown), Daniel Clemente, (unknown), (unknown), Nancy Liu, Christine Xu, (unknown), Angeliki Giannelou, (unknown), Bolanle Akinlade, (unknown)	0
3	Reducing the risk of visual disability for children with juvenile idiopathic arthritis uveitis through disease surveillance: past and future challenges 2025 ·Pediatric Rheumatology ·Ameenat Lola Solebo, Ivan Foeldvari	0
4	Physical (in)activity and screen-based media use of adolescents with juvenile idiopathic arthritis over time - data from a German inception cohort 2024 ·Pediatric Rheumatology ·(unknown), (unknown), Jens Klotsche, Ina Liedmann, Martina Niewerth, Anton Hospach, (unknown), (unknown), Frank Weller‐Heinemann, Ivan Foeldvari, Tilmann Kallinich, Johannes‐Peter Haas, Daniel Windschall, Frank Dressler, Dirk Foell, Jasmin Kuemmerle‐Deschner, Kirsten Minden	0
5	Pharmacokinetics, Efficacy, and Safety of Upadacitinib in Pediatric Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis: An Interim Analysis of an Open‐Label, Phase 1 Trial 2024 ·Arthritis Care & Research ·Hermine I. Brunner, Anna Shmagel, Gerd Horneff, Ivan Foeldvari, Jordi Antón, (unknown), Yuli Qian, (unknown), (unknown), Heidi S. Camp, Nasser Khan, (unknown), Mohamed‐Eslam F. Mohamed	4
6	Vergleich der Therapie mit JAK-Inhibitoren bei der juvenilen idiopathischen Arthritis in der klinischen Praxis und in den Zulassungsstudien 2024 ·Arthritis und Rheuma ·Gerd Horneff, Daniel Windschall, Kirsten Minden, Jasmin Kümmerle‐Deschner, Frank Dressler, Frank Weller‐Heinemann, Ivan Foeldvari, (unknown), Ariane Klein	0
7	Assessing Competencies, Needs, and Satisfaction With the Transition From Pediatric to Adult Health Care in Rheumatology: Development and Validation of the Transition-KompAZ 2024 ·The Journal of Rheumatology ·(unknown), Jens Klotsche, Martina Niewerth, Sandra Hansmann, (unknown), (unknown), Sebastian Saur, Paula Hoff, Eva Seipelt, (unknown), (unknown), (unknown), Ivan Foeldvari, Ina Kötter, Kirsten Minden	0
8	Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry 2024 ·RMD Open ·Jasmin Kuemmerle‐Deschner, Tilmann Kallinich, Jörg Henes, (unknown), Prasad T. Oommen, Jürgen Rech, (unknown), Frank Weller‐Heinemann, Gerd Horneff, Aleš Janda, Ivan Foeldvari, Catharina Schuetz, Frank Dressler, Michael Borte, Markus Hufnagel, Florian Meier, (unknown), (unknown), (unknown), Norbert Blank	9
9	What are Juvenile-onset systemic sclerosis providers thoughts, experiences, and reasons for autologous stem cell transplant? Result of a multinational survey 2024 ·Journal of Scleroderma and Related Disorders ·Ivan Foeldvari, (unknown), Suzanne C. Li, F.J. Rosser, Kathryn S. Torok	0
10	A practical approach to uveitis screening in children with juvenile idiopathic arthritis 2024 ·British Journal of Ophthalmology ·Ivan Foeldvari, (unknown), Harry Petrushkin, (unknown), Regitze Bangsgaard, (unknown), Tamás Constantin, Joke de Boer, (unknown), Clive Edelsten, Mia Glerup, (unknown), Sebastian Krämer, Elisabetta Miserocchi, Ellen Nordal, Rotraud K. Saurenmann, Gabriele Simonini, Ameenat Lola Solebo, (unknown), Jordi Antón	3
11	Best clinical practice in the treatment of juvenile systemic sclerosis: expert panel guidance - the result of the International Hamburg Consensus Meeting December 2022 2023 ·Expert Review of Clinical Immunology ·Ivan Foeldvari, Kathryn S. Torok, Jordi Antón, (unknown), Tamás Constantin, Maurizio Cutolo, Christopher P. Denton, Kim Fligelstone, Bernd Hinrichs, Suzanne C. Li, Susan Maillard, Edoardo Marrani, Pia Moinzadeh, Catherine H. Orteu, Clare Pain, John D Pauling, Clarissa Pilkington, F.J. Rosser, Vanessa Smith, (unknown)	2
12	Long‐Term Maintenance of Clinical Responses by Individual Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis Treated With Abatacept 2023 ·Arthritis Care & Research ·Hermine I. Brunner, Nikolay Tzaribachev, Ingrid Louw, Inmaculada Calvo Penadés, Francisco Ávila‐Zapata, Gerd Horneff, Ivan Foeldvari, D. Kingsbury, (unknown), Carine Wouters, Johannes Breedt, Robert Wong, Margarita Askelson, (unknown), Alberto Martini, Daniel J. Lovell, Nicolino Ruperto	1
13	Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis 2023 ·Lara D. Veeken ·Jelena Vojinović, Ivan Foeldvari, Joke Dehoorne, Violeta Panavienė, Gordana Sušić, Gerd Horneff, Valda Staņēvicha, (unknown), Zbigniew Żuber, (unknown), Jonathan Akikusa, Tadej Avčin, (unknown), Edmund Arthur, Svitlana Tatulych, Chuanbo Zang, (unknown), Bonnie Vlahos, Alberto Martini, Nicolino Ruperto	5
14	POS1321 MENTAL HEALTH SCREENING IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS 2021 ·Annals of the Rheumatic Diseases ·(unknown), Martina Niewerth, (unknown), Claudia Sengler, Daniel Windschall, Tilmann Kallinich, J. Grulich‐Henn, Frank Weller‐Heinemann, Ivan Foeldvari, Sandra Hansmann, Harald Baumeister, Reinhard W. Holl, Doris Staab, Kirsten Minden	3
15	Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial 2020 ·Annals of the Rheumatic Diseases ·Seza Özen, (unknown), Ivan Foeldvari, Gil Amarilyo, Huri Özdoğan, Steven Vanderschueren, (unknown), J. Michelle Kahlenberg, Elise Dekker, Fabrizio De Benedetti, Isabelle Koné‐Paut	50
16	Update on malignancies in children with juvenile idiopathic arthritis in the German BIKER Registry. 2017 ·PubMed ·Gerd Horneff, Ariane Klein, Prasad T. Oommen, Anton Hospach, Ivan Foeldvari, (unknown), Kirsten Minden	17
17	Induction and Maintenance of Remission By Etanercept in Enthesitis Related Arthritis JIA-Patients 2015 ·RWTH Publications (RWTH Aachen) ·Gerd Horneff, Ivan Foeldvari, Ralf Trauzeddel, Gerd Ganser, J. B. Kuemmerle‐Deschner, Kirsten Minden, Klaus Tenbrock, (unknown)	0
18	Juvenile and young adult-onset systemic sclerosis share the same organ involvement in adulthood: data from the EUSTAR database 2012 ·Lara D. Veeken ·Ivan Foeldvari, A Tyndall, Francesco Zulian, Ulf Müller‐Ladner, László Czirják, Christopher P. Denton, Otylia Kowal‐Bielecka, Dominique Farge Bancel, Marco Matucci‐Cerinic	29
19	Preliminary classification criteria for systemic sclerosis in children 2005 ·UCL Discovery (University College London) ·Francesco Zulian, Pamelyn J. Woo, (unknown), (unknown), Medsger Ta, (unknown), Marco Matucci‐Cerinic, Giorgia Martini, Angelo Ravelli, R.L. Russo, R Cuttica, (unknown), Christopher P. Denton, Ivan Foeldvari, (unknown)	4
20	Rapid development of severe osteoarthritis associated with osteoid osteoma in a young girl 1998 ·Clinical Rheumatology ·Ivan Foeldvari, Martin Schmitz	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact